First Bank Texas Rolls Out Mobile Banking Branch Across North and West Texas
New Mobile Branch Brings Full-Service Banking, Financial Education, and Local Bank Support to Communities from DFW to Abilene WILLOW PARK, Texas–(BUSINESS... Read more.
CloudWalk Earns Fraud Prevention Certification from Brazil’s National Confederation of Financial Institutions
Combining machine learning with cutting-edge innovations like LLM-based agents, the fintech has built a fraud shield that spots suspicious patterns, dismantles digital... Read more.
Applicate Commerce Welcomes John Mittenthal to its Board of Directors
KIRKLAND, Wash.–(BUSINESS WIRE)–Applicate Commerce, a leading distributor of applied architectural products, today announced the appointment of John... Read more.
ATS Reports Fourth Quarter and Fiscal 2025 Results
CAMBRIDGE, Ontario–(BUSINESS WIRE)–ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”) today reported its financial... Read more.
Klaviyo to Participate in William Blair 45th Annual Growth Stock Conference
BOSTON–(BUSINESS WIRE)–Klaviyo (NYSE: KVYO), the only CRM built for consumer brands, today announced that Amanda Whalen, Chief Financial Officer, will... Read more.
Erica White, SVP of Technology & Strategic Initiatives at Article Student Living, Recognized By GlobeSt. as a 2025 Woman of Influence
CHICAGO–(BUSINESS WIRE)–The editors of GlobeSt. have selected Erica White, Senior Vice President of Technology & Strategic Initiatives at Article... Read more.
Jeff Jochims Appointed Executive Chair at Genesee Scientific
Seasoned Life Sciences Executive to Guide Accelerated Growth SAN DIEGO–(BUSINESS WIRE)–Genesee Scientific, a leading provider of laboratory essentials... Read more.
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Wednesday,... Read more.
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 11-2 TRYPTYR is a first-in-class TRPM8 receptor agonist that rapidly... Read more.
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 11-2 TRYPTYR is a first-in-class TRPM8 receptor agonist that rapidly... Read more.